LONDON, UNITED KINGDOM--(Marketwired - Nov 30, 2016) - Plandaí Biotechnology, Inc. (OTCQB: PLPL) ("Plandaí" or "the Company"),
producer of the highly bioavailable Phytofare® catechin complex, is pleased to announce that they have received an initial
purchase order from Capital Brands LLC, distributor of the world famous, NutriBullet®, who will feature Phytofare® Catechin
Complex as an active ingredient in their nutrient extraction powder mix, "Superfood Fat Burning Boost®" which will be for sale
exclusively in the USA early in Q1 2017. NutriBullet, the maker of the popular nutrient extraction blender, has formulated
superfoods containing pea protein, fibers, antioxidants, and vitamins that can be easily combined into healthy smoothies.
The company uses GMO-free ingredients sourced from the world's most reputable farms that undergo extensive testing for purity,
effectiveness and flavor.
Callum Cottrell-Duffield, Vice President of sales and marketing for Plandaí Biotechnology, commented, "We are excited that a
company with such a sterling reputation for using quality sources for their ingredients has chosen to use our product to better
their own. Phytofare® is the only green tea catechin extract backed by human clinical studies which confirms that it has ten
times greater bioavailability over generic extracts. Green tea catechins have been widely studied and shown to promote weight
loss by increasing thermogenesis; however, poor bioavailability has historically hampered their effectiveness except at high
dosages, which can lead to nausea and other unwanted side effects. By using Phytofare® as the active ingredient, NutriBullet can
deliver a product at lower dosage points, but with greater therapeutic benefit. We look forward to a long a mutually profitable
relationship with NutriBullet LLC."
Dr. Rockway, VP of R&D for Capital Brands LLC, added, "We take great pride in insuring not only do our products meet the
highest quality standards, but also that we can deliver on the promises on our packaging. Adding Phytofare® Catechin Complex to
our SuperFood Fat Burning Boost® is a significant value add for many reasons. Not only is Phytofare® Catechin Complex clinically
proven in human studies to be a superior ingredient, but we are impressed with Plandaí's commitment to providing economic
empowerment to the South African people while also responsibly operating with a zero carbon footprint. These are all values that
we as a company and our customers share with Plandaí."
About Capital Brands LLC
Capital Brands LLC and its subsidiaries create, produce, and sell NutriBullet blenders as well as Superfood formula
mixes and other accessories for their blenders that help give the consumer the best possible health benefits using only the best
and most quality ingredients available. The company focuses on nutrient extraction in order to deliver the most nutrients
possible from food and other ingredients to increase the health of people everywhere. For more information, please visit https://www.nutribullet.com/. "NutriBullet" and "SuperFood Fat Burning
Boost" are the registered trademarks of Capbran Holdings, LLC.
About Plandaí Biotechnology, Inc.
Plandaí Biotechnology, Inc. and its subsidiaries develop highly phyto-available™ extracts. Plandaí Biotechnology
controls every aspect of the process, from growing the raw materials on its farms in South Africa, to producing its proprietary
Phytofare® extracts in-house, allowing the Company to guarantee the continuity of supply as well as quality control throughout
the entire process. Targeted industries for the Company's products include beverage, cosmeceutical, wellness, nutraceutical,
anti-aging, and pharmaceutical. For more information, please visit http://www.plandaibiotech.com.
Safe Harbor Statement
This release contains forward-looking statements that are based upon current expectations or beliefs, as well as a
number of assumptions about future events. Although we believe that the expectations reflected in the forward-looking statements
and the assumptions upon which they are based are reasonable, we can give no assurance or guarantee that such expectations and
assumptions will prove to have been correct. Forward-looking statements are generally identifiable by the use of words like
"may," "will," "should," "could," "expect," "anticipate," "estimate," "believe," "intend," or "project" or the negative of these
words or other variations on these words or comparable terminology. The reader is cautioned not to put undue reliance on these
forward-looking statements, as these statements are subject to numerous factors and uncertainties, including but not limited to:
adverse economic conditions, competition, adverse federal, state and local government regulation, international governmental
regulation, inadequate capital, inability to carry out research, development and commercialization plans, loss or retirement of
key executives and other specific risks. To the extent that statements in this press release are not strictly historical,
including statements as to revenue projections, business strategy, outlook, objectives, future milestones, plans, intentions,
goals, future financial conditions, events conditioned on stockholder or other approval, or otherwise as to future events, such
statements are forward-looking, and are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform
Act of 1995. The forward-looking statements contained in this release are subject to certain risks and uncertainties that could
cause actual results to differ materially from the statements made. Readers are advised to review our filings with the Securities
and Exchange Commission that can be accessed over the Internet at the SEC's website located at http://www.sec.gov.